Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Satsuma Pharmaceuticals Q4 EPS $(0.70) Misses $(0.36) Estimate

Author: Happy Mohamed | March 28, 2023 03:23pm
Satsuma Pharmaceuticals (NASDAQ:STSA) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.36) by 94.44 percent. This is a 42.86 percent decrease over losses of $(0.49) per share from the same period last year.

Posted In: STSA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist